Seems like Cambridge, MA, is buzzing with dollar signs. Many of the financings we spotted this week went to life sciences and Web companies in the city.
—MC10, a Cambridge-based developer of technology enabling electronics to bend and stretch, added $2.5 million in Series B funding, bringing the round’s total to $14.75 million. The new money comes from Windham Venture Partners; North Bridge Venture Partners and Braemar Energy Ventures previously invested in the round.
—Cambridge-based Locu, formerly known as Goodplates, raised $623,000 in seed financing from crop of Boston and Bay Area angel investors. The company, whose founders met at an MIT class focused on the semantic Web technology known as linked data, is developing a platform enabling restaurants to better manage menu content online.
—Aura Biosciences, a Cambridge-based developer of nano particles for cancer drug delivery, raised $4.5 million from a group of private individual investors in the pharmaceutical industry.
—More cha-ching for Cambridge. Backupify, a maker of Web technology for storing data from e-mail and social media applications, brought in $5 million in Series B money, led by existing investor Avalon Ventures. Return Backupify investors General Catalyst Partners and Lowercase Capital also participated in the deal, which will help the Cambridge-based company further develop its data backup technology for businesses that use Google Apps.
—Imaging and detection technology developer Caliper Life Sciences (NASDAQ: CALP) of Hopkinton, MA, will be acquired by PerkinElmer for $600 million in cash. Waltham, MA-based Perkin Elmer (NYSE: PKI) paid $10.50 per share for Caliper, a 42 percent premium on Caliper’s closing share price of $7.39 the day before the deal was announced. The transaction is expected to close sometime in the fourth quarter of this year.
—Take the Interview, of Cambridge, raised $775,000 in seed funding from angel investors, and partners and limited partners of the startup incubator program it participated in this summer, DreamIt Ventures. The company is developing technology for video-based job recruiting and marketing.
—Bedford, MA-based video surveillance technology developer VideoIQ inked a $7.5 million Series C investment from Atlas Venture, Cisco, Matrix Partners and Tenaya Capital, to put toward growth and product development.
—Tensha Therapeutics, a Cambridge-based epigenetic drug developer, raised $15 million in a Series A financing from HealthCare Ventures.